Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.91 USD | -2.35% | -7.03% | -30.88% |
05-02 | CUREVAC : A missed opportunity | |
04-26 | UBS Cuts CureVac Price Target to $14 From $18, Maintains Buy Rating | MT |
ETFs positioned on CureVac N.V.
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.74% | 17 M€ | -.--% | - | |
0.06% | 2 M€ | -.--% | ||
0.04% | 0 M€ | 0.00% | - | |
0.04% | 0 M€ | 0.00% | - | |
0.01% | 0 M€ | -.--% | - | |
0.00% | 10 M€ | -3.35% | - | |
0.00% | 0 M€ | +3.63% | - |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-30.88% | 652M | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- CVAC Stock
- Funds and ETFs CureVac N.V.